PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α
Lauren M. Thorpe(Harvard University), Jean J. Zhao(Harvard University)
Cited by 106
Related Papers
The oncogenic properties of mutant p110α and p110β phosphatidylinositol 3-kinases in human mammary epithelial cells
|Proceedings of the National Academy of Sciences|2005|327
The p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis
|Genes & Development|2012|125
A PI3K p110β–Rac signalling loop mediates Pten-loss-induced perturbation of haematopoiesis and leukaemogenesis
|Nature Communications|2015|48
Spatially distinct roles of class Ia PI3K isoforms in the development and maintenance of PTEN hamartoma tumor syndrome
|Genes & Development|2013|24
Lysine vitcylation is a novel vitamin C-derived protein modification that enhances STAT1-mediated immune response
|bioRxiv (Cold Spring Harbor Laboratory)|2023|2